METOPIMAZINE VENIPHARM 7.5 mg sugar-free, orodispersible tablet sweetened with aspartame 16 tablets
Active ingredients: Metopimazine
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet16 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- METOPIMAZINE VENIPHARM 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartam
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC PVDC de 16 comprimé(s)
- Marketing authorisation holder
- VENIPHARM
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Feb 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66179148CIP73024847CIP133400930248478Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTOPIMAZINEcomprimé | 7.5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.